Two malpractice cases — one worth $2 million — are reshaping the standards of gender-affirming care. This episode traces what went wrong, what held up in court, and what every clinician needs to know when referring patients for gender affirming procedures.
There are many effective medications for panic disorder, including tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs).
When Dr. Chris Aiken opened a psychotherapy practice in Western North Carolina, treatment-resistant depression wasn’t a specialty he planned for — it was what walked through the door. Most patients arrived having already failed one or more SSRIs prescribed in primary care. The standard next steps — raising the dose, switching classes, adding bupropion, buspirone, or a stimulant — often weren’t enough.
In August 2024, the American Journal of Psychiatry published a landmark update on PTSD by Arieh Shalev, MD, and colleagues at NYU — a comprehensive look at the diagnosis, neuroscience, and treatment of one of psychiatry’s most complex conditions. Dr. Chris Aiken, Editor-in-Chief of The Carlat Psychiatry Report, and his co-host Kellie Newsome, PMHNP took a deep dive into that article in this five-part podcast series.